Objective: Adolescent methamphetamine use has become a key issue for Canadian media and governments. Empirical studies, however, have not yet established the national scope of adolescent methamphetamine use or its impact on treatment services in Canada. The objective of the current study was to provide results from a national survey of primary methamphetamine-related admissions to Canadian residential substance abuse treatment facilities for youth.
A dolescent methamphetamine use has become a key issue for Canadian media and governments. [1] [2] [3] [4] Empirical studies, however, have not yet established the national scope of adolescent methamphetamine use or its impact on treatment services in Canada. Most of the available data on methamphetamine use among adolescents comes from provincial school-based surveys. For example, the McCreary 1998 and 2003 British Columbia Adolescent Health Surveys included about 25 000 to 30 000 seventh-to twelfth-graders in each survey cycle, and this research program found that lifetime use of amphetamines (a category including methamphetamine) remained relatively low and constant at 4% to 5%. 5 According to preliminary results from the Alberta Youth Experience Survey 2005, 1.2% of Alberta students in Grades 7 to 12 reported using crystal methamphetamine in the previous year. 6 The Ontario Student Drug Use Survey showed that the prevalence of any methamphetamine use in the past year has declined significantly in recent years, from 5.1% in 1999 to 2.6% in 2005. 7 In Prince Edward Island, New Brunswick, and Nova Scotia, the 2002 Atlantic Provinces' survey of youth in Grades 7, 9, 10, and 12 found that the point prevalence of amphetamine use in the last year ranged from 6% to 11%. [8] [9] [10] In addition, the 2004 Canadian Addiction Survey, a population-based survey of Canadians' alcohol and drug use, indicated that the rate of lifetime amphetamine use among respondents aged from 15 to 19 years was 8.3%. 11 In general, the available studies demonstrate that the estimated prevalence of adolescent methamphetamine use appears relatively low, especially in comparison with use of alcohol, tobacco, and marijuana. It is important to note that most of the available adolescent drug use surveys have collected information on the more inclusive drug class of amphetamines rather than on methamphetamine specifically . Therefore, these results provide an upper limit of methamphetamine use rather than a specific estimate.
In other countries experiencing high rates of adolescent methamphetamine-related problems, addiction-treatment records have served as a sentinel source of data for understanding the scope and spread of methamphetamine use. 12 For example, the 1992 to 2003 Treatment Episode Data Set (TEDS), the annual compilation of data on entry into publicly funded substance abuse treatment across the United States, showed that the rates of youth reporting their primary drug as methamphetamine rose significantly, from 0.8% in 1992 to 3.7% in 2003. 13 In addition, the TEDS has provided valuable information to US policy-makers and law enforcement agencies about the spread of problematic methamphetamine use from western to eastern states during the last decade. 14 A similar review of Canadian addiction-treatment records could establish the impact of problematic methamphetamine use on substance abuse facilities in this country. However, a national repository of admission data from substance abuse treatment centres is unfortunately not available in Canada. The current study aimed to provide a national survey of primary methamphetamine-related admissions to Canadian residential substance abuse treatment facilities for youth.
Method

Sampling Frame
To develop a comprehensive list of all of the Canadian residential substance abuse treatment facilities for youth, we solicited information from the Canadian Centre for Substance Abuse, Health Canada, the First Nation and Inuit Health Branch, each of the provincial and territorial ministries of health, all provincial drug and alcohol referral centres (for example, Drug and Alcohol Registry of Treatment in Ontario), and the executive directors (or equivalent) of the contacted centres.
Survey Questionnaire
As part of a larger survey on the service-delivery options in residential substance abuse treatment facilities for youth in Canada, we included the following 2 questions relevant to the current study: "Approximately how many adolescents are admitted to your program each year?" and "In the previous 12 months, approximately what percentage of clients sought treatment [at your centre] primarily for misuse of methamphetamine, including crystal methamphetamine?" The survey was conducted from May to September 2006.
Respondents
The executive director (or equivalent) of each facility provided the information for our survey.
Results
Even though the definition of "youth" varied across sites, the typical youth treatment centre in our survey provided service to adolescents aged from 13 to 19 years. Responses were received from 46 of the 50 centres on our final master list. Three centres provided "Don't know" answers to the methamphetamine-related survey question, and as a result, these centres were excluded from the analyses. Our final results included data from 43 treatment centres, with a combined annual caseload of 5411. Where the executive director provided an estimated range for the number of annual admissions and the proportion of those admissions primarily owing to methamphetamine, we used the midpoint of the range. About 20% (1109/5169) of all inpatient youth substance abuse treatment admissions were reported to be due primarily to methamphetamine.
For display purposes, we aggregated data from centres located in the same city by summing their caseloads and calculating a weighted mean of the proportion of admissions due primarily to methamphetamine use. This was done in Thunder Bay and Calgary (2 centres each) and in the Vancouver area (9 centres). In Figure 1 , the size of the circles represents the number of annual admissions, and the shading within the circles indicates the annual proportion of primary-methamphetamine related admissions. It is important to note that treatment centres, especially in rural areas, can draw admissions from broad catchment areas. As a result, treatment records reflect drug use patterns among treatment-seeking adolescents within a catchment area, rather than the city or town location of the treatment centre. As seen in Figure 1 , primary methamphetamine-related admissions appear concentrated in western Canada.
Discussion
In 2005 and 2006, primary methamphetamine-related admissions accounted for about 20% of all entries to Canadian residential substance abuse treatment facilities for youth. A large majority of primary methamphetamine-related admissions occurred in British Columbia and Alberta, and our results clearly demonstrate that adolescent methamphetamine use has had a major impact on youth residential addiction services in these 2 western provinces.
An apparent disjunction exists between the relatively high rates of primary methamphetamine-related admissions and the low rates of adolescent methamphetamine use found in school-and population-based surveys. Several reasons may explain this pattern. The sample of treatment-seeking adolescents in our study probably represents a more marginalized at-risk population-a group likely outside the reach of school-or population-based surveys. For example, in one of our prior addiction treatment studies examining methamphetamine-related harms, roughly one-half of the youth were not currently enrolled in school at the time of inpatient admission. 15 In addition, other researchers have found high rates of past-year methamphetamine use among streetinvolved youth and lesbian, gay, bisexual, transgender, and questioning youth in Vancouver and Victoria. 16, 17 At this time, the available evidence shows that elevated patterns of methamphetamine use appear in more marginalized high-risk groups of adolescents but not in the broader population of youth across Canada.
Elevated rates of the primary methamphetamine-related admissions also trigger concerns about appropriate substance abuse treatment strategies, but relatively little empirical evidence currently exists to guide a best-practices approach for adolescent methamphetamine misuse. Several researchers have proposed the Matrix Model, a cognitive-behavioural therapy-based methamphetamine-specific substance abuse treatment program, to deal effectively with increasing levels of methamphetamine-related treatment admissions. 18 Some studies have demonstrated that primary methamphetamineand nonmethamphetamine-using adolescents respond similarly to cognitive-behavioural therapy-based treatment. 15, 19 Other evidence has shown that, in response to a range of treatment-as-usual approaches, primary methamphetamine users manifest treatment completion and readmission patterns similar to those of primary cocaine, heroin, or other opiate users but worse outcomes than primary alcohol or marijuana users. 20 It is also important to note that in adult samples methamphetamine-specific treatment has not produced superior posttreatment improvement in comparison with a range of standard treatment-as-usual protocols. 21 Our results must be interpreted in light of several limitations. The treatment data in our current study cannot be used to make adolescent drug abuse prevalence estimates for Canada. Our data only represent the drug use patterns of adolescents entering inpatient substance abuse treatment and likely exclude most adolescent drug users who are unable or unwilling to access inpatient treatment. Also, it is important to note that a time lag exists between problematic drug use and treatment entry, and as a result, our data may not reflect current methamphetamine use trends. In addition, at about 50% of the treatment centres, our study relied on the estimates of the executive directors about the annual caseload and primary methamphetamine-related admissions at their treatment centre. In these instances, it is possible that the executive directors' estimates may not match exactly the actual records in their administrative databases.
Our project stands as the first national study on the impact of adolescent methamphetamine use on addiction-treatment services in Canada. Elevated rates of primary methamphetamine-related admissions appeared primarily in British Columbia and Alberta. In addition, our national survey adds to the emerging evidence that elevated use rates of methamphetamine appear to be situated in more marginalized, at-risk groups of adolescents, rather than in the broader population of adolescents in Canada. Future monitoring of youth addiction-treatment records will provide longitudinal evidence about the spread of problematic methamphetamine use among adolescents in Canada, and this information will aid policy-makers, treatment providers, and law enforcement agencies to develop effective strategies to limit methamphetamine-related harms among youth.
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Résumé : Une enquête nationale sur les premières admissions liées à la méthamphétamine dans des centres de traitement résidentiels de la toxicomanie pour les jeunes au Canada, de 2005 à 2006
Objectif : L'utilisation de méthamphétamine chez les adolescents est devenue un problème important pour les médias et le gouvernement canadiens. Toutefois, les études empiriques n'ont pas encore établi l'étendue nationale de l'utilisation de méthamphétamine chez les adolescents ou de ses répercussions sur les services de traitement au Canada. La présente étude a fourni une enquête nationale sur les premières admissions liées à la méthamphétamine dans des centres de traitement résidentiels de la toxicomanie pour les jeunes.
Méthode : Nous avons dressé une liste exhaustive de tous les centres de traitement résidentiels canadiens de la toxicomanie pour les jeunes puis, nous avons interrogé le directeur général (ou l'équivalent) de chaque établissement sur le nombre de cas annuel et la proportion de premières admissions liées à la méthamphétamine au cours des 12 derniers mois.
Résultats :
Des réponses ont été reçues de 46 centres sur les 50 de notre liste de base finale. Environ 20 % (1 109/5 169) de toutes les admissions nationales dans des centres de traitement résidentiels de la toxicomanie pour les jeunes ont été imputées principalement à l'utilisation de méthamphétamine. La grande majorité des premières admissions liées à la méthamphétamine ont eu lieu en Colombie-Britannique et en Alberta.
Conclusions : L'utilisation de méthamphétamine chez les adolescents a eu un effet majeur sur les entrées dans les centres de traitement résidentiels de la toxicomanie de Colombie-Britannique et d'Alberta, alors que seulement quelques centres en dehors de ces deux provinces de l'Ouest ont connu des taux élevés de premières admissions liées à la méthamphétamine. Étant donné la rareté des études sur le traitement des adolescents utilisant la méthamphétamine, la recherche future doit mettre l'accent sur l'élaboration de stratégies cliniques efficaces en ce domaine.
